FDA OK’s biosimilair drug of Amgen's Neupogen chemo recovery drug

March 8, 2015 3:51 PM

6 0

The FDA has recently approved a biosimilair drug in the US. The approval of the drug will have far reaching consequences for the multibillion dollar biologic drug market. What exactly is a Biogenic drug and why is it in news today? The expensive biogenic drugs are all set to become cheaper as less costly alternatives with similar action are available.

Biologic drugs are not covered under the 1984 law that cleared the way for low-cost generic pharmaceuticals. Biogenic drugs are so complex and expensive and are made of living cells, blood or tissues and are difficult to be copied. However with advances in science it is possible to make biosimilair ...

Also read: Mattel and Schlumberger slide while Honeywell jumps

Read more

To category page